Image Credit: Canva
When was the last time you measured your waistline? If you assume that BMI is the only number to focus on when it comes to your health, think twice. New research has revealed a shocking revelation—your waist circumference might be a far better predictor of men's cancer risk than BMI.
The study finds that for each 4-inch increase in waist size, a man's risk of cancer increases by a staggering 25%. Meanwhile, BMI, commonly regarded as the gold standard for assessing obesity, raises cancer risk by only 19% for the same weight gain. So, if you've been dismissing that pesky belly fat, it's time to take notice.
But why is your waistline so important? The reason is visceral fat—the hidden, deep fat that accumulates around your organs. Unlike other body fat, visceral fat is a stealthy troublemaker, causing inflammation, insulin resistance, and abnormal blood fat levels—all of which combine to create a cancer-perfect storm.
Obesity has been associated with an increased risk of numerous health conditions, including cancer, for decades. The research, though, indicates that a specific measure of the body—waist circumference—may be an even more reliable forecaster of cancer risk in men than the more frequently employed Body Mass Index (BMI). This finding emphasizes the need to pay particular attention to the distribution of fat and not merely to the weight of the body.
BMI has been the go-to measure for years for gauging health risks related to obesity. New research, though, that appears in The Journal of the National Cancer Institute indicates that waist measurement is a better predictor of cancer risk in men. According to the research, four more inches (10 cm) around the waist will add 25% to a man's cancer risk. Conversely, a 3.7 kg/m² rise in BMI (from a BMI of 24 to 27.7) increased cancer risk by only 19%.
Why is waist circumference a better predictor, then? Unlike BMI, which measures weight relative to height, waist circumference actually measures abdominal fat—specifically, visceral fat. This type of fat encircles internal organs and is also linked to higher levels of inflammation, insulin resistance, and abnormal blood lipids, all of which are factors in cancer growth. BMI, however, does not measure fat distribution, so two individuals with the same BMI can have very different levels of health risk depending on where fat is deposited on their bodies.
Interestingly, the research identified a significant difference between men and women when it came to waist circumference and cancer risk. Although waist circumference and BMI were linked with obesity-related cancers in women, the relationship was weaker than for men. An increase of 12 cm (4.7 inches) in waist size or a 4.3 rise in BMI (from 24 to 28.3) raised the cancer risk in women by just 13%—a much lower percentage than for men.
Experts credit this difference to the way that fat is stored in the body. Men are more likely to carry fat around the abdomen, especially as visceral fat, which is more metabolically active and associated with cancer-producing biological alterations. Women, by contrast, store fat in peripheral sites such as the hips and thighs, where it is less likely to drive systemic inflammation and metabolic disturbances.
A possible reason is that men tend to depot fat more in the visceral regions, whereas women tend to carry more subcutaneous and peripheral fat," wrote the researchers. "This may render waist circumference a more robust risk factor for cancer in men and account for why waist circumference provides additional risk information beyond BMI in men but not women."
The research used the International Agency for Research on Cancer (IARC) data to define obesity-related cancers. These cancers are esophageal (adenocarcinoma), gastric (cardia), colorectal, rectal, liver, gallbladder, pancreatic, renal, and thyroid cancers, and multiple myeloma and meningioma. In men, abdominal obesity is especially significant in raising the risk of these cancers through high levels of insulin and markers of inflammation.
For women, the research proposes that both waist circumference and hip circumference may give a more accurate estimate of visceral fat and cancer risk. "Adding hip circumference to risk models could strengthen the link between waist circumference and cancer, especially in women," researchers observed.
With these results, doctors advise men to be more mindful of their waistline than only their BMI. Waist size is an easy method to gauge health risk, and its maintenance through lifestyle changes might be the key to cancer prevention.
Track Your Waist Size: Regularly measure your waist circumference and try to keep it in a healthy range (below 40 inches for men, according to medical advice).
Eat a Balanced Diet: A diet containing high fiber, lean protein, and healthy fats can assist in limiting visceral fat gain.
Exercise Consistently: Regular exercise with a combination of aerobic and strength training will help maintain a healthy waistline.
Control Stress and Sleep: Persistent stress and inadequate sleep tend to cause weight gain, especially in the midsection of the body.
Regular Health Screenings: Early identification of cancer risk factors through regular screening can greatly enhance long-term health status.
Credits: Canva
Vaccines are among the most powerful tools in modern medicine, preventing millions of deaths each year. Yet getting those vaccines safely from laboratories to people who need them is far more complicated than many realise. Most vaccines must be kept within a strict temperature range between 2°C and 8°C from the moment they are produced until they are administered.
This temperature controlled system, known as the cold chain, depends on refrigerators, insulated transport boxes and a steady supply of electricity at every step of the journey. Any disruption can damage the vaccine and make it ineffective. Now, scientists are testing a new technology that could remove this challenge altogether.
A vaccine designed to remain stable even at room temperature has shown encouraging results in an early human trial. Researchers believe this could change how vaccines are distributed, especially in regions where refrigeration is difficult to maintain.
Vaccines are sensitive biological products. Exposure to excessive heat or freezing temperatures can damage their active ingredients and reduce their ability to trigger an immune response.
To avoid this, countries rely on a carefully managed cold chain that transports vaccines from manufacturing facilities to warehouses, regional storage centers and finally to clinics. This process requires specialised equipment, trained staff and constant monitoring of temperatures.
However, maintaining this system is both expensive and complex. Equipment failures, power outages and transport delays can disrupt the cold chain at any stage. In rural or remote regions where electricity supply is unreliable, these challenges become even more serious.
Global health experts estimate that a large number of vaccines are lost every year because of temperature control failures during storage and transport. This leads to wasted doses, increased costs and gaps in vaccination coverage.
Because of these difficulties, scientists have long been searching for ways to develop vaccines that can remain effective without strict refrigeration.
One promising development is a vaccine candidate called SPVX02, which targets tetanus and diphtheria. It has been developed by the biotechnology company Stablepharma with support from the UK Health Security Agency.
What makes this vaccine different is the technology used to stabilize its active ingredients. The formulation allows the vaccine to tolerate higher temperatures without losing potency.
Early findings from a Phase I clinical trial suggest the vaccine can remain stable at around 30°C for as long as two years. The study was carried out at the Vaccine Development and Evaluation Centre in the United Kingdom and involved healthy volunteers.
Phase I trials are the earliest stage of human testing. At this stage, researchers focus mainly on safety, possible side effects and the body’s immune response.
If further trials confirm these findings, the same stabilization technology could potentially be applied to other vaccines as well.
A fridge free vaccine could have major implications for countries such as India, which runs one of the largest immunization programmes in the world.
India’s Universal Immunisation Programme delivers vaccines to millions of children every year. To reach remote villages and urban settlements, the programme depends on a vast cold chain network that includes refrigerated storage facilities, specialized transport and vaccine carriers.
Maintaining this infrastructure across a country with varied climates and uneven electricity supply can be difficult. Heat exposure during transport or power failures can lead to spoilage and wastage.
A thermostable vaccine that remains effective at room temperature could simplify this process significantly. It would reduce dependence on refrigeration, lower costs and make it easier to deliver vaccines in remote or resource limited areas.
Although the early results are encouraging, the vaccine still needs to go through larger clinical trials before it can be approved for widespread use.
Future studies will involve more participants and compare the new formulation with existing refrigerated vaccines to confirm its effectiveness.
If the technology proves successful, researchers believe it could be adapted for many other vaccines in the future. That possibility could reshape how immunization programmes operate worldwide and help bring life saving vaccines to communities that have long struggled to access them.
Credits: Wikimedia Commons
A federal judge in Massachusetts has blocked a series of vaccine policy changes introduced by U.S. Health Secretary Robert F. Kennedy Jr., dealing a significant setback to the Trump administration’s health agenda. The ruling temporarily halts new vaccine recommendations and reverses recent decisions made by the government’s vaccine advisory panel.
The decision was issued by Judge Brian Murphy of the U.S. District Court for the District of Massachusetts. It came after several medical organizations argued that the government’s actions were not based on scientific evidence and could endanger public health.
In his ruling, Judge Murphy said vaccine policy decisions have traditionally been based on careful review of scientific data. This process is also required under federal law.
However, he wrote that the government had ignored these standards while introducing changes to vaccination guidelines. According to the court, the decisions undermined the integrity of the process that normally guides national immunization recommendations.
The ruling stops the government from implementing those changes for now. It also means the Advisory Committee on Immunization Practices, or ACIP, cannot hold its scheduled meeting this week.
The case was brought by six major medical organizations, including the American Academy of Pediatrics. They claimed that the new policies changed the childhood vaccine schedule without proper scientific review.
The groups argued that the government had made “arbitrary and capricious” decisions by bypassing the usual evidence-based process. They also questioned the qualifications of several members appointed to the vaccine advisory committee.
Judge Murphy noted in his ruling that only six of the 15 committee members appeared to have meaningful experience with vaccines. The committee is responsible for recommending which vaccines Americans should receive and when.
Read: 15 States Sue Trump Administration Over Revised Vaccine Schedule
The lawsuit focused on a series of policy changes introduced over the past year. These included reducing the number of diseases covered under the routine childhood immunization schedule.
In January 2026, federal officials announced a new vaccine schedule that lowered the number of diseases children are routinely vaccinated against from 17 to 11.
The changes also affected recommendations for Covid vaccines. Earlier in 2025, Kennedy announced that Covid shots would no longer be recommended for healthy children or pregnant women.
Health officials supporting the changes argued that growing mistrust of vaccines had reduced vaccination rates. They believed simplifying the schedule might rebuild public confidence.
However, critics said the changes were rushed and not supported by strong scientific review.
Many doctors and public health experts strongly opposed the new policies. They warned that weakening vaccine recommendations could lead to outbreaks of preventable diseases.
Medical groups say childhood vaccination programs have been one of the most successful public health efforts in modern history. Vaccines protect children from serious diseases such as measles, polio and hepatitis B.
Several organizations also filed supporting legal documents in the case, including public health experts and research groups.
Officials from the Department of Health and Human Services said the government plans to challenge the ruling. A spokesperson said the administration expects the decision to be overturned.
For now, however, the court order means previous vaccine recommendations will remain in place.
Medical organizations welcomed the ruling. They said it helps restore a science-based process that has guided vaccine policy for decades and protected the health of millions of children.
Read: CDC Vaccine Schedule: Coverage Falls From 17 to 11 Diseases For Children
The federal health department sought to reduce the number of shots American children receive, announced that the new Centers for Disease Control and Prevention (CDC), vaccine schedule will include routine shots for 11 diseases for children. This is down from 17 diseases, which were earlier included. Jim O'Neill, who is the acting director of the CDC updated the agency's immunization schedule to reflect the changes, effective immediately.
The most controversial change is the narrowing of recommendations for several common childhood vaccines. Immunization against the following illnesses is now advised only for high-risk children or after consultation with a health care provider:
Covid-19 vaccination has also shifted to a consultation-based recommendation rather than routine use for all children.
This means shots that were once automatically given at set ages, including at birth, during infancy, and in adolescence, may now depend on individual medical discussions rather than standard guidance.

Credits: Canva
Water remains the most reliable and effective way to keep the body hydrated during hot weather. However, many people have increasingly turned to energy drinks during long workdays or busy schedules, hoping to stay refreshed or energized.
Experts warn that relying on these drinks instead of water can create several health risks, particularly when temperatures are high.
Energy drinks are typically marketed as quick solutions for fatigue and low energy. They often contain high levels of caffeine, added sugars and stimulants that may temporarily increase alertness.
While this short term boost may seem appealing, experts say these drinks are not designed to support proper hydration. When consumed frequently, especially during summer, they can place extra strain on the body rather than helping it stay cool and hydrated.
Dr Arun Sachdeva, an Internal Medicine Specialist at Felix Healthcare in Bengaluru, explains that replacing water with energy drinks during hot weather can interfere with the body’s natural hydration balance.
According to him, excessive consumption of these beverages may contribute to both immediate and long term health concerns, particularly when the body is already losing fluids through sweating.
During summer, when sweating already causes significant water loss, this effect may make it harder for the body to maintain proper hydration.
When energy drinks replace water intake, the risk of dehydration increases. Common symptoms of dehydration include fatigue, dizziness, headaches and dry mouth. In more severe cases, dehydration can also affect concentration, physical performance and overall wellbeing.
For people who already have high blood pressure or existing heart conditions, excessive intake of energy drinks could increase the risk of heart palpitations or irregular heart rhythms. Experts therefore recommend limiting the consumption of these beverages, particularly during periods of intense heat.
Frequent spikes in blood sugar levels may gradually increase the risk of metabolic disorders. Over time, consistently high sugar consumption can contribute to health problems such as obesity and type 2 diabetes.
Therefore, doctors advise paying attention to sugar content in beverages, especially during hot weather when people tend to drink more fluids throughout the day.
Instead of providing sustained energy, regular consumption of energy drinks may lead to temporary stimulation followed by sudden drops in energy levels.
This cycle can leave individuals feeling even more tired later in the day, creating a pattern where they rely on more caffeinated drinks to stay alert.
When the body does not receive enough water, the kidneys may struggle to function efficiently. Over time, poor hydration can increase the risk of kidney related problems and may affect the body’s ability to regulate fluid levels effectively.
Doctors emphasize that water remains the safest and most effective drink for maintaining hydration during summer. It helps regulate body temperature, supports organ function and replaces fluids lost through sweating without introducing excess caffeine, sugar or stimulants.
Energy drinks may occasionally provide a quick boost of alertness, but they should not be used as a substitute for water. Maintaining regular water intake throughout the day remains one of the simplest and most effective ways to support overall health during hot weather.
© 2024 Bennett, Coleman & Company Limited